Expert Rev Pharmacoeconomics Outcomes Res. 2012;12(3):319-333. The most recent biologic therapy to receive marketing approval, tocilizumab, was evaluated in a 24-week, randomized, placebo ...

But BiologIC Technologies believes its system can produce more than medicines. It also has the potential to make food and raw materials from basic biological ingredients. That adaptability is ...